These results suggest that using TSPAN1-positive EVs or their combination with CEA or CA19–9 can increase the efficacy of diagnosis and that this strategy for discovering small-EV markers for cancer diagnosis is effective. The gene discussed is TSPAN1; the disease is cancer.